Quantra (hemostasis system)

2022: System Announcement

On November 30, 2022, HemoSonics announced the release of the Quantra hemostasis system with a QStat cartridge. In particular, it can be used for injuries and liver transplantation procedures.

HemoSonics developed a new generation system to expand Quanta's overall diagnostic capabilities. According to the press release, the device covers the widest range of indications among all hemostasis analyzers produced in the United States. The device uses SEER sonorheometry. Patented medical grade ultrasound technology helps measure the coagulation properties of a whole blood sample.

Quantra (hemostasis system)

The system allows physicians to perform patient-centered coagulation therapy. The company said the system improves the quality of treatment and optimizes the use of blood products. It also features quick results, ease of use and a screen with dials for easy interpretation.

{{quote 'The Quantra Hemostasis System with QStat cartridge opens up new possibilities and is the leading innovative development in the whole blood hemostasis analyzers market, both in the point of care and in the laboratory! Today's approval significantly expands the clinical indications for the use of the Quantra system, creating the broadest opportunities to meet the critical unmet clinical needs of our partners - the medical institutions and patients we serve, said HemoSonics President and CEO Robert Roda. }} The platform can be used in a variety of health care settings, including operating rooms, emergency rooms, and intensive care units. HemoSonics offers the Quantra system with QPlus and QStat cartridges commercially in the United States, as well as in Europe, Australia, New Zealand, Japan and Hong Kong.^[1]

Notes